Showing results (1901-1910 of 2,369) with videos related to
Sort By:
Pageof 237
Future Medicinal Chemistry|August 22, 2015
Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancerShelley B Hooks, Mandi M MurphFuture Medicinal Chemistry|August 22, 2015
Emerging drugs in refractory colorectal cancerStefania Nobili, Alessandro Galletta, Marco Brugia, et al.Future Medicinal Chemistry|May 30, 2019
Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragmentsAnja Kolarič, Doroteja Novak, Matjaž Weiss, et al.Future Medicinal Chemistry|May 30, 2019
Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategyDong Wang, Zhaoyang Li, Yi Liu, et al.Future Medicinal Chemistry|April 9, 2019
Visnagin and benzofuran scaffold-based molecules as selective cyclooxygenase-2 inhibitors with anti-inflammatory and analgesic properties: design, synthesis and molecular dockingHazem Sa Khalil, Nada K Sedky, Kamelia M Amin, et al.Future Medicinal Chemistry|April 10, 2019
Hemocompatibility of amyloid and/or brain targeted liposomesGeorgios Pa Michanetzis, Eleni Markoutsa, Spyridon Mourtas, et al.Future Medicinal Chemistry|June 9, 2018
3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking studyRashad Al-Salahi, Rohaya Ahmad, ElHassane Anouar, et al.Future Medicinal Chemistry|May 12, 2018
Dithiolethiones: a privileged pharmacophore for anticancer therapy and chemopreventionMohd Imran Ansari, Mohd M Khan, Mohammad Saquib, et al.Future Medicinal Chemistry|May 12, 2018
Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief reviewGulmira Turdu, Hongwei Gao, Yingying Jiang, et al.Future Medicinal Chemistry|May 22, 2018
Design, synthesis and biological evaluation of chromenopyrimidines as potential cytotoxic agentsNehal M El-Bakhshawangy, Hala B El-Nassan, Asmaa E Kassab, et al.Pageof 237